SALOFALK 500 TABLET 500 mg

DCH AURIGA SINGAPORE

DCH AURIGA SINGAPORE

Therapeutic

Prescription Only

ENTERIC COATED TABLET

**4.2 Posology and method of administration** Posology _Adults_ Depending upon the clinical requirements in individual cases, the following daily doses are recommended:  Method of administration Salofalk 500mg should be taken in the morning, at midday and in the evening, 1 hour before meals. They should be swallowed whole, not chewed, and taken with plenty of fluid. Treatment with Salofalk 500mg should be administered regularly and consistently, both during the acute inflammatory stage and during maintenance therapy in order to achieve the desired therapeutic effect. The duration of use is determined by the physician. An acute exacerbation of ulcerative colitis or Crohn’s disease generally subsides after 8–12 weeks. For relapse prophylaxis of ulcerative colitis the dose can usually be reduced to 1.5 g mesalazine/day. Note In rare cases, in patients who have undergone bowel resection/ bowel surgery in the ileocoecal region with removal of the ileocoecal valve, it has been observed that Salofalk 500mg, gastro-resistant tablets, were excreted undissolved in the stool, due to an excessively rapid intestinal passage.